1108731-49-2

Basic information

• Product Name: Alogliptin Impurity C
• Synonyms: Alogliptin Impurity C
• CAS NO: 1108731-49-2
• Molecular Formula: C20H23N5O3
• Molecular Weight: 381.43
• Mol File: 1108731-49-2.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.33±0.1 g/cm3(Predicted)
• PKA: 15.79±0.20(Predicted)
• CAS DataBase Reference: Alogliptin Impurity C(CAS DataBase Reference)
• NIST Chemistry Reference: Alogliptin Impurity C(1108731-49-2)
• EPA Substance Registry System: Alogliptin Impurity C(1108731-49-2)

Safety Data

• Hazardous Substances Data: 1108731-49-2(Hazardous Substances Data)

Usage

Description

Alogliptin Impurity C, also known as (5S)-5-Amino-7-[2-[(4,5-diphenyl-1,3-oxazol-2-yl)amino]propionyl]-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine-4-carboxylic acid, is a chemical impurity associated with alogliptin, a medication used to treat type 2 diabetes. It is a byproduct formed during the synthesis of alogliptin and plays a crucial role in ensuring the quality, safety, and efficacy of the final drug product.

Uses

Used in Pharmaceutical Manufacturing:
Alogliptin Impurity C is used as a quality control parameter in the manufacturing of alogliptin, a medication for treating type 2 diabetes. Monitoring and controlling the presence of this impurity is essential to ensure that the final drug product meets regulatory standards and is safe for consumption.
Used in Regulatory Compliance:
Alogliptin Impurity C is used as a benchmark for regulatory compliance in the pharmaceutical industry. Identifying and characterizing impurities like Alogliptin Impurity C in alogliptin helps ensure that the medication adheres to safety and efficacy guidelines set by regulatory authorities.
Used in Research and Development:
Alogliptin Impurity C serves as a subject of research and development in the pharmaceutical sector. Understanding the properties and effects of this impurity can contribute to the improvement of alogliptin synthesis processes and the overall quality of the medication.